X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5777) 5777
Newspaper Article (99) 99
Newsletter (64) 64
Magazine Article (5) 5
Book / eBook (2) 2
Book Review (1) 1
Dissertation (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5377) 5377
oncology (3267) 3267
female (3188) 3188
male (3101) 3101
cancer (2627) 2627
middle aged (2620) 2620
head (2473) 2473
aged (2105) 2105
adult (1880) 1880
squamous cell carcinoma (1875) 1875
head and neck cancer (1606) 1606
carcinoma, squamous cell - virology (1536) 1536
tumors (1482) 1482
human papillomavirus (1473) 1473
squamous-cell carcinoma (1324) 1324
prognosis (1287) 1287
head and neck neoplasms - virology (1276) 1276
carcinoma, squamous cell - pathology (1244) 1244
papillomavirus infections (1209) 1209
medicine (1191) 1191
survival (1151) 1151
research article (1104) 1104
head and neck neoplasms - pathology (1091) 1091
research (1001) 1001
science (993) 993
head & neck cancer (991) 991
aged, 80 and over (985) 985
multidisciplinary sciences (980) 980
neck-cancer (975) 975
risk factors (959) 959
surgery (920) 920
expression (911) 911
papillomavirus infections - virology (866) 866
analysis (859) 859
patients (845) 845
immunohistochemistry (843) 843
hpv (823) 823
oropharyngeal neoplasms - virology (822) 822
papillomavirus infections - complications (805) 805
carcinoma, squamous cell - genetics (798) 798
health aspects (798) 798
cell line, tumor (788) 788
metastasis (785) 785
pathology (784) 784
care and treatment (778) 778
animals (775) 775
chemotherapy (767) 767
gene expression (725) 725
otorhinolaryngology (722) 722
neck (696) 696
head and neck neoplasms - genetics (692) 692
cancer therapies (683) 683
oropharyngeal cancer (673) 673
squamous cell carcinoma of head and neck (665) 665
human-papillomavirus (650) 650
radiotherapy (641) 641
dna (635) 635
carcinoma (632) 632
medical prognosis (627) 627
proteins (618) 618
retrospective studies (618) 618
genetic aspects (608) 608
carcinoma, squamous cell - metabolism (603) 603
papillomaviridae - isolation & purification (592) 592
apoptosis (575) 575
mice (566) 566
cancers and neoplasms (558) 558
polymerase chain reaction (555) 555
studies (550) 550
risk (547) 547
radiation therapy (546) 546
medical research (540) 540
neoplasm staging (534) 534
prevalence (522) 522
deoxyribonucleic acid--dna (510) 510
diagnosis (508) 508
head and neck neoplasms - metabolism (504) 504
infection (482) 482
epidemiology (479) 479
papillomaviridae - genetics (472) 472
otolaryngology (467) 467
cell biology (461) 461
head and neck squamous cell carcinoma (457) 457
metastases (450) 450
papillomaviruses (446) 446
development and progression (437) 437
biology (435) 435
medicine and health sciences (430) 430
treatment outcome (426) 426
mutation (408) 408
biomarkers (407) 407
gene expression regulation, neoplastic (398) 398
p16 (396) 396
carcinoma, squamous cell - mortality (392) 392
head and neck tumors (385) 385
carcinoma, squamous cell - therapy (384) 384
oropharyngeal neoplasms - pathology (383) 383
stomatognathic diseases (379) 379
head and neck neoplasms - therapy (375) 375
genes (372) 372
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5908) 5908
French (23) 23
German (19) 19
Portuguese (12) 12
Chinese (10) 10
Japanese (7) 7
Spanish (6) 6
Czech (5) 5
Amharic (1) 1
Finnish (1) 1
Hungarian (1) 1
Icelandic (1) 1
Italian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 9, pp. 1566 - 1575
...) patients with nonoropharyngeal (non‐OP) head and neck squamous cell cancers (HNSCCs). METHODS This retrospective, multi... 
human papillomavirus (HPV) | head and neck squamous cell cancer (HNSCC) | p16 | race | sex | oropharyngeal squamous cell cancer (OPSCC) | prognosis | UNITED-STATES | POSITIVE HEAD | IN-SITU HYBRIDIZATION | IMPROVED SURVIVAL | TRIAL | NASOPHARYNGEAL CARCINOMA | HPV STATUS | THERAPY | ONCOLOGY | IMMUNOHISTOCHEMISTRY | Oropharyngeal Neoplasms - ethnology | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prognosis | Asian Americans - statistics & numerical data | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Nasopharyngeal Neoplasms - ethnology | Nasopharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - mortality | Hispanic Americans - statistics & numerical data | Male | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - ethnology | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Mouth Neoplasms - ethnology | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Head and Neck Neoplasms - ethnology | Laryngeal Neoplasms - ethnology | Female | Papillomavirus Infections - virology | Retrospective Studies | Repressor Proteins - metabolism | Oncogene Proteins, Viral - metabolism | Ethnic Groups - statistics & numerical data | Papillomavirus Infections - epidemiology | Proportional Hazards Models | European Continental Ancestry Group - statistics & numerical data | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Mouth Neoplasms - mortality | Human papillomavirus 16 - metabolism | Head and Neck Neoplasms - pathology | African Americans - statistics & numerical data | Papillomavirus E7 Proteins - metabolism | Laryngeal Neoplasms - mortality | Sex Factors | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Mouth Neoplasms - pathology | Head and Neck Neoplasms - mortality | Neoplasm Staging | DNA, Viral | Human papillomavirus 16 - genetics | Laryngeal Neoplasms - virology | Complications and side effects | Care and treatment | DNA | Head and neck cancer | Research | Papillomavirus infections | Risk factors | Sex | Risk | Population studies | mRNA | Nasopharynx | Human papillomavirus | Race | Larynx | Deoxyribonucleic acid--DNA | Squamous cell carcinoma | Head | Adjustment | Mortality | Health risks | Hazards | Ribonucleic acid--RNA | Minority & ethnic groups | Patients | Survival | Oral cavity | Tobacco | Medical prognosis | Men | Health hazards | Health risk assessment | Hispanics | Cancer | Tumors
Journal Article
British journal of cancer, ISSN 0007-0920, 01/2019, Volume 120, Issue 2, pp. 256 - 268
BACKGROUND: High-risk human papilloma viruses (HPV) are a causative agent of anogenital and oropharyngeal cancers. Patients treated for a preinvasive or... 
UTERINE CERVIX | LONG-TERM RISK | ONCOLOGY | ANOGENITAL CANCER | SQUAMOUS-CELL CARCINOMA | FOLLOW-UP | POOLED ANALYSIS | HUMAN-PAPILLOMAVIRUS | INVASIVE CANCERS | CERVICAL INTRAEPITHELIAL NEOPLASIA | CARCINOMA IN-SITU | Head and Neck Neoplasms - virology | Humans | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - virology | Male | Uterine Cervical Neoplasms - pathology | Oropharyngeal Neoplasms - pathology | Papillomavirus Infections - pathology | Penile Neoplasms - epidemiology | Vulvar Neoplasms - pathology | Penile Neoplasms - pathology | Carcinoma in Situ - epidemiology | Head and Neck Neoplasms - epidemiology | Female | Papillomavirus Infections - virology | Anus Neoplasms - epidemiology | Penile Neoplasms - virology | Carcinoma in Situ - pathology | Papillomavirus Infections - epidemiology | Risk Factors | Vaginal Neoplasms - pathology | Vulvar Neoplasms - virology | Anus Neoplasms - pathology | Oropharyngeal Neoplasms - virology | Vaginal Neoplasms - virology | Head and Neck Neoplasms - pathology | Neoplasms, Second Primary - epidemiology | Oropharyngeal Neoplasms - epidemiology | Papillomaviridae - pathogenicity | Carcinoma in Situ - virology | Neoplasms, Second Primary - virology | Vaginal Neoplasms - epidemiology | Vulvar Neoplasms - epidemiology | Uterine Cervical Neoplasms - virology | Neoplasms, Second Primary - pathology | Tumour virus infections | Cancer epidemiology
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1078 - 1085
... [HPV(+)] versus human papillomavirus-unrelated [HPV(−)] head-and-neck cancer (HNC). Methods and Materials All cases of N2-N3 HNC treated with radiation therapy/chemoradiation therapy between 2003 and 2009 were reviewed... 
Radiology | Hematology, Oncology and Palliative Medicine | METASTASIS | ONCOLOGY | DISSECTION | OROPHARYNGEAL CANCER | LYMPH-NODES | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | CHEMORADIOTHERAPY | HUMAN-PAPILLOMAVIRUS | RADIOTHERAPY | ONCOLOGY GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Multivariate Analysis | Head and Neck Neoplasms - virology | Lymph Nodes - pathology | Hypopharyngeal Neoplasms - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Laryngeal Neoplasms - pathology | Lymph Nodes - radiation effects | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Adult | Female | Papillomavirus Infections - virology | Remission Induction - methods | Oropharyngeal Neoplasms - drug therapy | Laryngeal Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Organ Size | Oropharyngeal Neoplasms - radiotherapy | Treatment Outcome | Lymph Nodes - virology | Oropharyngeal Neoplasms - virology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - surgery | Hypopharyngeal Neoplasms - pathology | Aged | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Neoplasm Staging | Head and Neck Neoplasms - surgery | Cohort Studies | Laryngeal Neoplasms - virology | Neck Dissection | Sects | Care and treatment | Radiotherapy | Nuclear radiation | Papillomavirus infections | Cancer | HEAD | MULTIVARIATE ANALYSIS | NEOPLASMS | LYMPH NODES | POSITRON COMPUTED TOMOGRAPHY | CHARGES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | LARYNX | HAZARDS
Journal Article
American journal of obstetrics and gynecology, ISSN 0002-9378, 2008, Volume 198, Issue 5, pp. 500.e1 - 500.e7
Objective The purpose of this study was (1) to estimate the direct medical costs of 7 major noncervical human papillomavirus (HPV)–related conditions that... 
Obstetrics and Gynecology | cost analysis | economic burden | human papillomavirus | HEAD | COST-EFFECTIVENESS | NEONATAL CIRCUMCISION | CARE | OBSTETRICS & GYNECOLOGY | RECURRENT RESPIRATORY PAPILLOMATOSIS | ANAL CANCER | SQUAMOUS-CELL CARCINOMA | GENITAL WARTS | VULVA | NECK | Warts - economics | United States - epidemiology | Vulvar Neoplasms - economics | Humans | Cost of Illness | Anus Neoplasms - virology | Male | Pharyngeal Neoplasms - virology | Respiratory Tract Neoplasms - economics | Human papillomavirus 18 | Penile Neoplasms - epidemiology | Human papillomavirus 16 | Neoplasms - virology | Human papillomavirus 11 | Female | Anus Neoplasms - epidemiology | Oropharyngeal Neoplasms - economics | Respiratory Tract Neoplasms - virology | Penile Neoplasms - virology | Costs and Cost Analysis | Neoplasms - economics | Papilloma - virology | Penile Neoplasms - economics | Human papillomavirus 6 | Mouth Neoplasms - economics | Papilloma - economics | Pharyngeal Neoplasms - economics | Vulvar Neoplasms - virology | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Vaginal Neoplasms - virology | Papillomavirus Infections - economics | Oropharyngeal Neoplasms - epidemiology | Vaginal Neoplasms - epidemiology | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - epidemiology | Vaginal Neoplasms - economics | Anus Neoplasms - economics | Neoplasms - epidemiology | Papillomaviruses | Medical economics | Papillomavirus infections
Journal Article
Cancer, ISSN 0008-543X, 01/2018, Volume 124, Issue 1, pp. 203 - 211
BACKGROUND Human papillomavirus (HPV) vaccines can potentially prevent greater than 90% of cervical and anal cancers as well as a substantial proportion of... 
human papillomavirus (HPV) cancer | relative survival | HPV‐associated cancer | HPV-associated cancer | UNITED-STATES | HEAD | POPULATION | PREVALENCE | NECK-CANCER | ONCOLOGY | OROPHARYNGEAL CANCER | SQUAMOUS-CELL CARCINOMA | SURVEILLANCE | BURDEN | INCIDENCE TRENDS | Head and Neck Neoplasms - virology | Age Factors | United States | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | African Americans | Anus Neoplasms - virology | Male | Incidence | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Rectal Neoplasms - virology | Adult | Female | Papillomavirus Infections - virology | Uterine Cervical Neoplasms - mortality | Vulvar Neoplasms - mortality | Databases, Factual | Penile Neoplasms - mortality | Penile Neoplasms - virology | Papillomavirus Infections - epidemiology | Vulvar Neoplasms - virology | European Continental Ancestry Group | Survival Rate | Oropharyngeal Neoplasms - virology | Vaginal Neoplasms - virology | Rectal Neoplasms - mortality | Vaginal Neoplasms - mortality | Anus Neoplasms - mortality | Uterine Cervical Neoplasms - virology | Papillomaviridae | Head and Neck Neoplasms - mortality | Prevention | Cancer patients | Diagnosis | Anal cancer | Cervical cancer | Squamous cell carcinoma | Invasiveness | Vaccination | Sex | Vagina | Vaccines | Cervix | Patients | Survival | Public domain | Screening | Demographics | Human papillomavirus | Penis | Race | Rectum | Cervical carcinoma | Age | Cancer
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 276 - 283
... (10 of 12) of HPV– additional head-and-neck (HN) mucosal malignancies were in the... 
Radiology | Hematology, Oncology and Palliative Medicine | Distant metastasis | Clinical characteristics | Human papillomavirus | Oropharyngeal carcinoma | Second primary | HEAD | FIELD CANCERIZATION | LOWER GENITAL-TRACT | CERVICAL-CARCINOMA | METASTASES | HUMAN-PAPILLOMAVIRUS DNA | NECK-CANCER | CARCINOGENESIS | ONCOLOGY | INFECTION | ASSOCIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Smoking - adverse effects | Head and Neck Neoplasms - virology | Age Factors | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | DNA, Viral - isolation & purification | Male | Oropharyngeal Neoplasms - pathology | Neoplasms, Multiple Primary - radiotherapy | Carcinoma, Squamous Cell - radiotherapy | Neoplasms, Second Primary - radiotherapy | Human papillomavirus 16 - isolation & purification | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Aged, 80 and over | Adult | Female | Mouth Neoplasms - radiotherapy | Neoplasms, Multiple Primary - virology | Papillomavirus Infections - virology | Retrospective Studies | Papillomavirus Infections - complications | Biomarkers, Tumor - analysis | Oropharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Neoplasms, Multiple Primary - pathology | Alcohol Drinking - adverse effects | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Neoplasms, Second Primary - virology | Mouth Neoplasms - pathology | Carcinoma, Squamous Cell - secondary | Aged | Human papillomavirus 16 - genetics | Neoplasms, Second Primary - pathology | Cohort Studies | Care and treatment | Squamous cell carcinoma | Radiotherapy | Nuclear radiation | Papillomavirus infections | Cancer | PHARYNX | PATIENTS | ORAL CAVITY | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | MUCOUS MEMBRANES
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 67, pp. 174 - 182
...−) locally advanced head and neck cancer (LAHNC) treated with chemoradiotherapy (CRT). Patients and methods A pooled analysis was conducted of stage III/IV oropharyngeal cancer (OPC... 
Hematology, Oncology and Palliative Medicine | Head and neck cancer | Human papillomavirus | Survival | Chemoradiotherapy | Cisplatin | THERAPY | ONCOLOGY | OROPHARYNGEAL CANCER | RADIOTHERAPY | EXPRESSION | Oropharyngeal Neoplasms - therapy | Head and Neck Neoplasms - virology | Hypopharyngeal Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Case-Control Studies | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Aged, 80 and over | Adult | Female | Retrospective Studies | Papillomavirus Infections - complications | Head and Neck Neoplasms - therapy | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Oropharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - complications | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Carcinoma, Squamous Cell - complications | Hypopharyngeal Neoplasms - pathology | Radiotherapy, Conformal | Head and Neck Neoplasms - complications | Aged | Hypopharyngeal Neoplasms - complications | Neoplasm Staging | Laryngeal Neoplasms - complications | Laryngeal Neoplasms - virology | Radiotherapy, Intensity-Modulated | Papillomaviruses | Antimitotic agents | Squamous cell carcinoma | Antineoplastic agents | Papillomavirus infections
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 2011, Volume 333, Issue 6046, pp. 1157 - 1160
Journal Article
Oral oncology, ISSN 1368-8375, 2013, Volume 49, Issue 1, pp. 79 - 85
Summary Objectives To describe the natural course of distant metastases (DMs) following radiotherapy (RT) or chemoradiotherapy (CRT) in HPV(+) oropharyngeal... 
Otolaryngology | Hematology, Oncology and Palliative Medicine | Distant metastasis | Human papillomavirus | Oropharyngeal carcinoma | Radiotherapy | Chemoradiotherapy | SURVIVAL | HEAD | HUMAN-PAPILLOMAVIRUS | P16(INK4A) | SUBSET | PHASE-III TRIAL | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | DENTISTRY, ORAL SURGERY & MEDICINE | SQUAMOUS-CELL CARCINOMA | EPSTEIN-BARR-VIRUS | NECK-CARCINOMA | Oropharyngeal Neoplasms - therapy | Papillomavirus Infections - radiotherapy | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Carcinoma - virology | Salvage Therapy | Male | Papillomavirus Infections - therapy | Neoplasm Recurrence, Local - pathology | Lung Neoplasms - secondary | Tongue Neoplasms - virology | Aged, 80 and over | Adult | Female | Retrospective Studies | Tonsillar Neoplasms - therapy | Liver Neoplasms - secondary | Carcinoma - secondary | Tongue Neoplasms - radiotherapy | Liver Neoplasms - virology | Radiotherapy Dosage | Tongue Neoplasms - therapy | Alphapapillomavirus - classification | Oropharyngeal Neoplasms - radiotherapy | Survival Rate | Oropharyngeal Neoplasms - virology | Carcinoma - radiotherapy | Lung Neoplasms - virology | Tonsillar Neoplasms - radiotherapy | Tonsillar Neoplasms - virology | Skin Neoplasms - virology | Skin Neoplasms - secondary | Carcinoma - therapy | Aged | Neoplasm Staging | Cohort Studies | Care and treatment | Metastasis | Nuclear radiation | Papillomavirus infections | Cancer
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2013, Volume 49, Issue 11, pp. 2522 - 2530
... However, treatment for head and neck cancer, including OSCC has gradually become intensified with chemoradiotherapy, accelerated radiotherapy and sometimes... 
Hematology, Oncology and Palliative Medicine | CD8+ TILs | Clinical outcome | Base of tongue cancer | CD4+ TILs | Tonsillar cancer | HPV | CD4 | CD8 | TILs | HEAD | PROGNOSIS | VACCINE | RISK | CERVICAL-CANCER | NECK-CANCER | ONCOLOGY | CD4(+) TILs | OROPHARYNGEAL CANCER | CD8(+) TILs | EPIDEMIC | EXPRESSION | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Tonsillar Neoplasms - immunology | CD4-Positive T-Lymphocytes - immunology | Papillomaviridae - immunology | Squamous Cell Carcinoma of Head and Neck | Tongue Neoplasms - virology | Aged, 80 and over | Papillomavirus Infections - immunology | Adult | Female | Papillomavirus Infections - virology | Tonsillar Neoplasms - therapy | Tonsillar Neoplasms - pathology | Tongue Neoplasms - therapy | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Treatment Outcome | Papillomaviridae - isolation & purification | Carcinoma, Squamous Cell - immunology | Tongue Neoplasms - pathology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - immunology | Pilot Projects | Tonsillar Neoplasms - virology | Aged | Tongue Neoplasms - immunology | CD8-Positive T-Lymphocytes - immunology | Biomarkers, Tumor - immunology | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 20, pp. 4013 - 4021
BACKGROUND Over the last decade, the causal link between human papillomavirus (HPV) infection and squamous cell carcinoma of the anus (SCCA) has been well... 
human papillomavirus (HPV) | second primary malignancy | anal cancer | Surveillance, Epidemiology, and End Results (SEER) | standardized incidence ratios | UNITED-STATES | DIAGNOSIS | HPV INFECTION | PREVENTION | POPULATION-BASED ANALYSIS | and End Results (SEER) | PREVALENCE | Epidemiology | CERVICAL INTRAEPITHELIAL NEOPLASIA | STRATEGIES | WOMEN | Surveillance | ONCOLOGY | MALIGNANCIES | Genital Neoplasms, Male - epidemiology | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - virology | Male | Risk | Pharyngeal Neoplasms - virology | Genital Neoplasms, Female - epidemiology | Incidence | Genital Neoplasms, Male - virology | Squamous Cell Carcinoma of Head and Neck | Head and Neck Neoplasms - epidemiology | Aged, 80 and over | Adult | Female | Papillomavirus Infections - virology | Retrospective Studies | Anus Neoplasms - epidemiology | SEER Program | Carcinoma, Squamous Cell - epidemiology | Papillomavirus Infections - epidemiology | Risk Factors | Survivors | Mouth Neoplasms - virology | Genital Neoplasms, Female - virology | Neoplasms, Second Primary - epidemiology | Mouth Neoplasms - epidemiology | Neoplasms, Second Primary - virology | Sex Factors | Pharyngeal Neoplasms - epidemiology | Uterine Cervical Neoplasms - virology | Papillomaviridae | Aged | Complications and side effects | Cancer patients | Care and treatment | Papillomavirus infections | Anal cancer | Risk factors | Squamous cell carcinoma | Health risks | Infections | Medical screening | Pharynx | Patients | Genital cancers | Confidence intervals | Oral cavity | Human papillomavirus | Anus | Men | Health risk assessment | Cancer
Journal Article